Drugs Made In America Acquisition II Corp. Ordinary Shares
DMII | NASDAQ
$10.20
$0.00 (0.00%)
At close: Oct 30, 2026, 3:59 PM ET
$10.19
-$0.01 (-0.10%)
After-hours:
Oct 30, 2026, 4:02 PM ET
TTM Period Ending | TTM 2026 Jun 30, 2026 | TTM 2026 Mar 31, 2026 | TTM 2025 Dec 31, 2025 | TTM 2025 Sep 30, 2025 | TTM 2025 Jun 30, 2025 | TTM 2025 Mar 31, 2025 | TTM 2024 Dec 31, 2024 |
|---|---|---|---|---|---|---|---|
PE Ratio | 33.53 | 43.35 | 61.88 | -551.96 | n/a | -791.03Qu | -4.12K |
PEG Ratio | n/a | -0.71 | -0.01 | n/a | n/a | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 1.01 | 1.01 | 0.27 | 0.06 | -1.53K | -3.57K | -5.39K |
P/FCF Ratio | -392.71 | -449.87 | -129.19 | -38.87 | n/a | n/a | -3.24K |
P/OCF Ratio | -392.71 | -449.87 | -129.19 | -38.87 | n/a | n/a | -3.24K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0 | 0 | n/a | n/a | -1.39 | -1.42 | -2.14 |
Quick Ratio | 0.34 | 0.53 | 0.09 | 1.32 | 0.04 | 0.04 | 0.23 |
Current Ratio | 0.34 | 0.53 | 0.09 | 1.32 | 0.04 | 0.04 | 0.23 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | 2.66% | 2.35% | 1.73% | -0.09% | 51.48% | 33.70% | 129.99% |
Return on Assets | 2.53% | 1.68% | 0.83% | -0.03% | -122.65% | -96.11% | -109.89% |
Return on Invested Capital | -0.29% | -0.28% | -0.27% | -0.04% | -132.11% | -107.76% | -113.75% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove DMII